British biopharma start-up Mereo to list in London

LONDON, June 6 (Reuters) - Mereo BioPharma Group, a

British company trialing three drugs developed by Novartis

, said it would list on London's junior AIM market to

raise capital to develop its drugs and give it more financial

flexibility for further deals.

Read more